Abstract P1-13-22: Establishment and characterization of two ER+/HER2- XPDX models developed sequentially before and after acquired resistance to the CDK4/6 inhibitor palbociclib from a patient with metastatic breast cancer
Varma, Ashwin, Flores, Johnnie, Simonson, Alyssa, Stackpole, Anna, Papadopoulos, Kyriakos P., Patnaik, Amita, Rasco, Drew, Beeram, Muralidhar, Sandera, Marisa, Wick, Michael
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article